Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

An Analysis of Diabetes Control in Puerto Rico

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2010 by Center for Diabetes Control, Inc..
Recruitment status was:  Enrolling by invitation
Novo Nordisk A/S
Eli Lilly and Company
Information provided by:
Center for Diabetes Control, Inc. Identifier:
First received: May 4, 2010
Last updated: May 5, 2010
Last verified: May 2010
Project: An analysis of Diabetes Control in Puerto Rico Hypothesis: This project seeks to determine the causes for: i) poor adherence to prescribed treatment by patients, ii) low compliance by providers with national guidelines iii) barriers impose by health insurance in control of diabetes mellitus iv) effectiveness of a disease management program for treatment adherence by patients.

Diabetes Mellitus
Arterial Hypertension

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: An Analysis of Variables That Affect Quality of Diabetes Control in Puerto Rico

Further study details as provided by Center for Diabetes Control, Inc.:

Estimated Enrollment: 600
Study Start Date: March 2010
Estimated Study Completion Date: February 2013
Estimated Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)
Detailed Description:

Method (s) The study will consist of three phases:

i) assessment phase,

ii) multimedia health education campaign for patients, providers and local health insurances for adherence improvement

iii) reassessment phase.

Target Population:

Phase I: 600 Hispanic, male and female, residents of Puerto Rico with a diagnosis of type 1 and 2 diabetes mellitus older than 18 of age.

Phase II: 600 patients identified in phase I with individualize health education interventions on the importance of adherence to prescribed medical treatment. 2) Spanish speaking population of Puerto Rico, health service providers, and health insurance companies through a multimedia health education campaign.

Phase III: reassessment of the 600 patients of Phase I.

Data Collection Tools:

i) Demographic information will be obtained by an interview questionnaire. Patients will be assigned a control number automatically by the data system.

ii) Laboratory blood samples for A1C, lipids (total cholesterol, triglycerides and HDL cholesterol), and serum creatinine.

iii) A comprehensive educational adherence program with different media strategies such as: radio spots, newspaper articles, public service announcements, telemedicine services.

Data Analysis: Data will be analyzed using SPSS for Windows.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
This epidemiologic study will analyzed a 600 type 1 and 2 Diabetic patients under medication. The populations to be analyzed is composed of female and male subjects under therapy with anti diabetic medication. The population will be selected from four high density cities in the Island of Puerto Rico. Puerto Ricans are considered as hispanic populations with a mix of white hispanic, african people on a basis of indians ancestry. Subjects will be invited to participate in the study.

Inclusion Criteria:

  • Type 1 and 2 diabetic patients older tha 18 years old

Exclusion Criteria:

  • 1. Hemophilia.
  • 2. Persons younger than 18.
  • 3. Persons in research studies of some drug.
  • 4. Persons using steroids.
  • 5. Patients with acute infections.
  • 6. Pregnant diabetic patients.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01117831

Sponsors and Collaborators
Center for Diabetes Control, Inc.
Novo Nordisk A/S
Eli Lilly and Company
Principal Investigator: Efrain Rodriguez-Vigil, MD Center for Diabetes Control, Inc.
  More Information

Responsible Party: Efrain Rodriguez-Vigil, MD, Medical Director, Center for Diabetes Control, Inc. Identifier: NCT01117831     History of Changes
Other Study ID Numbers: CD0108
Study First Received: May 4, 2010
Last Updated: May 5, 2010

Keywords provided by Center for Diabetes Control, Inc.:
Diabetes mellitus

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Lipid Metabolism Disorders
Vascular Diseases
Cardiovascular Diseases processed this record on May 25, 2017